Risk Factors of Daptomycin-Induced Eosinophilic Pneumonia in a Population with Osteoarticular Infection.
Laura Soldevila-BoixaderBernat VillanuevaMarta UlldemolinsEva BenaventAriadna PadullesAlba RiberaIrene BorrasJavier ArizaOscar MurilloPublished in: Antibiotics (Basel, Switzerland) (2021)
Clinicians should monitor cumulative daptomycin dosage to minimize DEP risk, and be cautious particularly in older patients when the total dose of daptomycin exceeds 10 g.